Karbassi
Abdolreza Karbassi, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20150244399 | Ultra-broadband Programmable Hybrid Step Attenuator - Systems and methods for partitioning the frequency spectrum for use in a plurality of function circuits, including step attenuation, phase modulation, and gain amplification functional circuits. A system may include a programmable step attenuator including selection circuitry and functional circuitry. First selection circuitry may include a plurality of outputs and may receive a signal and selectively provide the signal to an output based on the signal's frequency. First circuitry may be coupled to one of the outputs and may operate as a first step attenuator for signals in a first portion of the frequency spectrum. Second circuitry may be coupled to another output and operate as a second step attenuator for signals in a second portion of the frequency spectrum. Second selection circuitry may be coupled to the first and second circuitry and may provide a step attenuated signal from the first or second portion of the frequency spectrum. | 08-27-2015 |
Behjatolah Karbassi, Little Rock, AR US
| Patent application number | Description | Published |
|---|---|---|
| 20130095480 | Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status - A method of determining a prognosis of a cancer in a human comprising: determining expression level of CHST11 in a cancer tissue sample or determining methylation status of CHST11 gene in a cancer tissue sample. CHST11 is Carbohydrate (Chondroitin 4) Sulfotransferase 11. | 04-18-2013 |
Behjatolah M. Karbassi, Little Rock, AR US
| Patent application number | Description | Published |
|---|---|---|
| 20090136488 | Inhibition of cancer metastasis - P-Selectin on platelets and endothelium binds cell surface chondroitin sulfate (CS) proteoglycans, which are abundantly and stably expressed on the surface many cancer cells. Binding of the cancer cells through the CS moieties may be blocked to inhibit the interaction of cancer cells with platelets and endothelium. The present inventors disclose compositions and methods for the inhibition of cancer metastasis. | 05-28-2009 |
| 20140248290 | INHIBITION OF CANCER METASTASIS - P-Selectin on platelets and endothelium binds cell surface chondroitin sulfate (CS) proteoglycans, which are abundantly and stably expressed on the surface many cancer cells. Binding of the cancer cells through the CS moieties may be blocked to inhibit the interaction of cancer cells with platelets and endothelium. The present inventors disclose compositions and methods for the inhibition of cancer metastasis. | 09-04-2014 |